Hypoalbuminaemia after Ilunocitinib (Zenrelia) in dogs
The FDA has received 53 reports of hypoalbuminaemia in dogs after Ilunocitinib. That is 2.4% of all reports for this medicine, compared with 0.6% across reports for all dog medicines, so it is reported unusually often with this medicine.
53Reports
40%Marked serious
7.5%Recovered
21%Died or euthanised
106 daysTypical onset
Sponsored
How soon it started
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Ilunocitinib controls itching from allergies (tablet, a JAK inhibitor).
Products with this ingredient include Zenrelia. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
Questions owners ask
- Can Ilunocitinib cause hypoalbuminaemia in dogs?
- 53 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- How soon after a dose was it reported?
- In half of the reports with dates, it started within 106 days of the first dose.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Hypoalbuminaemia with similar medicines
- Hypoalbuminaemia after Oclacitinib (Apoquel) 424 reports · 1.5% of its reports
- Hypoalbuminaemia after Cyclosporine (Atopica) 204 reports · 1.3% of its reports
All reported side effects of Ilunocitinib in dogs · Medicines most reported with hypoalbuminaemia